Angioplasty overused among millions of patients, evidence shows
Every day, thousands of people enter hospitals for angioplasties—a procedure that will cost about $12,000, take a week of recuperation, and require a year or more of drug therapy. And, in many cases, it's probably unnecessary. Angioplasties have grown into a $10 billion industry in the United States, and there is no dispute that they can be a lifesaver for patients in the throes of a heart attack. But angioplasties aren't risk-free, and evidence is mounting that the procedure is overused among the millions of patients who have the kind of stable heart disease that doesn't foretell a heart attack. New studies indicate that cardiologists often don't evaluate these patients adequately before doing angioplasties, and patients often have inflated ideas about how important an angioplasty is to their survival.
- EHR Systems 'Immature, Costly,' AMA Says
- Anthem Blue Cross, 7 CA Health Systems Create New Challenger, Business Model
- Interstate Medical Licensure Effort Advances
- Data Points to Boom in Private HIX
- Few Winners Among MSSP Participants
- Better HCAHPS Scores Protect Revenue
- How to Build a Health Plan from Scratch
- Technology Lights Up Health Innovation Forum
- Insurers see cost hikes in Partners HealthCare (MA) mergers
- Malnourishment 'Epidemic' Plagues Hospitals? Really?